Renaissance Capital logo

TetraLogic Pharmaceuticals Priced, Nasdaq: TLOG

Developing small molecule therapeutics for the treatment of cancer.

Industry: Health Care

First Day Return: 0.0%

Industry: Health Care

Developing small molecule therapeutics for the treatment of cancer.
more less
IPO Data
IPO File Date 10/18/2013
Offer Price $7.00
Price Range $7.00 - $7.00
Offer Shares (mm) 7.2
Deal Size ($mm) $50
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 12/11/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $50
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Malvern, PA, United States
Founded 2001
Employees at IPO 20
Website www.tetralogicpharma.com

TetraLogic Pharmaceuticals (TLOG) Performance